New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

+ Follow Us

 

Upcoming Events

  1. Al’s Ride to Beat ALS

    August 25 @ 9:00 am - August 26 @ 3:30 pm
  2. St. George Garden Club

    August 25 @ 5:00 pm - 7:00 pm
  3. Two For The Road Show

    August 25 @ 8:00 pm - 11:00 pm
  4. Gospel Country Music Night

    August 30 @ 7:00 pm
  5. Grow Up Cannabis Conference

    September 7 @ 8:00 am - September 8 @ 5:00 pm

+ On-Air & Shows